FDA approves first medical device ADHD treatmentUS regulators have given the green-light for the first medical device to treat attention deficit hyperactivity disorder (ADHD). Share XFDA approves first medical device ADHD treatmenthttps://pharmaphorum.com/news/fda-approves-neurosigma-adhd/
The Bloc promotes Jennifer Matthews to CEO and presidentNew York-based healthcare creative agency The Bloc has promoted managing partner Jennifer Matthews to CEO and president. It’s Share XThe Bloc promotes Jennifer Matthews to CEO and presidenthttps://pharmaphorum.com/news/the-bloc-promotes-jennifer-matthews-ceo/
Boehringer’s blockbuster Spiriva under pressure, profits downBoehringer Ingelheim has announced an increase in sales for full year 2018, but a slight decline in profits, Share XBoehringer’s blockbuster Spiriva under pressure, profits downhttps://pharmaphorum.com/news/boehringer-ingelheim-2018-sales-profits/
Catalent acquires gene therapy specialist Paragon for $1.2bnDrug delivery technology provider Catalent is to acquire gene therapy company Paragon for $1.2 billion. Paragon specialises in Share XCatalent acquires gene therapy specialist Paragon for $1.2bnhttps://pharmaphorum.com/news/catalent-acquires-gene-therapy-paragon/
Mesoblast poised to file cell therapy for GVHD in USAustralian biotech Mesoblast can go ahead with a US filing for its off-the-shelf stem cell therapy for acute Share XMesoblast poised to file cell therapy for GVHD in UShttps://pharmaphorum.com/news/mesoblast-cell-therapy-gvhd-fda/
Hall & Partners promotes Sue Klinck to global people roleHall & Partners has promoted Sue Klinck to the newly-created role of global head of people and culture. Share XHall & Partners promotes Sue Klinck to global people rolehttps://pharmaphorum.com/news/hall-partners-sue-klinck/
Gillian Wain and Sue Eales join comms agency Makara HealthMakara Health has boosted its team with the appointments of Gillian Wain as account director and Sue Eales Share XGillian Wain and Sue Eales join comms agency Makara Healthhttps://pharmaphorum.com/news/gillian-wain-sue-eales-makara-health/
4th Annual Antibody Drug Conjugates (ADC) Summit: From Target to TherapeuticsWe are pleased to invite you to the 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics Share X4th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeuticshttps://pharmaphorum.com/partner-content/4th-annual-antibody-drug-conjugates-adc-summit-from-target-to-therapeutics/
FCB Health NY makes Kathleen Nanda executive creative directorKathleen Nanda has been promoted to executive creative director of FCB Health New York. She joined the communications Share XFCB Health NY makes Kathleen Nanda executive creative directorhttps://pharmaphorum.com/news/fcb-health-new-york-kathleen-nanda/
